Bosch Health Campus Logo Bosch Health Campus Logo
Home
Team
Dina Mönch
Scientist

Dr. Dina Mönch


Tel +49-711-8101 5759

Major Projects

  • Biomarkerstudies
  • Combination Therapies

Selected References

Koch, J., Beil, J., Berchtold, S., Mönch, D., Maaß, A., Smirnow, I., Schenk, A., Carter, M.E., Kloker, L.D., Leibold, T., Renner, P., Dahlke, M..-H., Lauer, U.M. (2023) Establishing a new platform to investigate the efficacy of oncolytic virotherapy in a human ex vivo peritoneal carcinomatosis model, Viruses , 15, 363
Koch, J., Mönch, D., Maaß, A., Mangold, A., Gužvić, M., Mürdter, T., Leibold, T., Dahlke, M.-H., Renner, P. (2022). Pharmacologic Targeting of MMP2/9 Decreases Peritoneal Metastasis Formation of Colorectal Cancer in a Human Ex Vivo Peritoneum Culture Model. Cancers (Basel) 14, 3760
Mönch, D., Koch, J., Maaß, A., Janssen, N., Mürdter, T., Renner, P., Fallier-Becker, P., Solaß, W., Schwab, M., Dahlke, M.-H., et al. (2021). A human ex vivo coculture model to investigate peritoneal metastasis and innovative treatment options. Pleura Peritoneum
Koch, J., Mönch, D., Maaß, A., Gromoll, C., Hehr, T., Leibold, T., Schlitt, H.J., Dahlke, M.-H., and Renner, P. (2021). Three dimensional cultivation increases chemo- and radioresistance of colorectal cancer cell lines. PLOS ONE 16, e0244513
Mönch, D., Bode-Erdmann, S., Kalla, J., Sträter, J., Schwänen, C., Falkenstern-Ge, R., Klumpp, S., Friedel, G., Ott, G., Kalla, C., et al. (2018). A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy. Oncotarget 9, 20781–20794

Curriculum Vitae

Education and Professional Career

Since 2018

Scientist at the Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany (Prof. Marc-H. Dahlke)

2015-2018

PhD Thesis (Prof. Dr. German Ott) Preliminary Title: “Identifizierung potentieller Zielgene für die Therapie von Pleuramesotheliomen“ and scientist at the Molecular Diagnostics Unit of the department of Clinical Pathology, Robert-Bosch-Hospital (Dr. Annette Staiger)

2014

Master Thesis at the Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany (Prof. Dr. Matthias Schwab, Dr. Oliver Burk). “Regulation der Genexpression durch die Fremdstoff-aktivierten Kernrezeptoren CAR und PXR in menschlichen Nierenzellen“

2009-2014

Studies in Biology at the University of Hohenheim, Stuttgart, Germany